🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

"Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Continuous Glucose Monitoring"

Recruitingn/aAges 18 Years - anyAllMedical University of Warsaw
NCT07286500 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This observational study examines whether sexual activity influences the risk of hypoglycemia in adults with type 1 or type 2 diabetes treated with insulin therapy and using continuous glucose monitoring (CGM). Many patients report fear of hypoglycemia during or after sexual activity, which may affect their quality of life and willingness to engage in intimate relationships. However, no systematic research has been conducted on this topic, largely due to the sensitive nature of sexual health and the previous lack of tools to remotely monitor glucose profiles. The study uses CGM systems (LibreView or Dexcom Clarity) to evaluate glucose changes during and up to 6 hours after sexual activity. Participants will mark the start of sexual activity in their CGM application using a neutral symbol (such as a heart icon). Data will be collected remotely through secure, certified platforms without

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged ≥18 years. * Diagnosis of type 1 or type 2 diabetes. * Current use of a continuous glucose monitoring (CGM) system. * Treatment with insulin therapy in any regimen. * Ability to operate the CGM application and mark the start of sexual activity. * Willingness to participate for 3 months. * Signed informed consent. Exclusion Criteria: * Inability to independently use the CGM application. * No sexual activity during the study period. * Withdrawal of consent at any time. * Any condition that, in the opinion of the investigator, prevents safe participation.
💊

What it tests

  • No intervention
📍

Where

1 site
Medical University of Warsaw, CSK UCK
Warsaw, Poland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy